Endexx Corporation
Endexx Corporation EDXC Peers
See (EDXC) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EDXC | $0.01 | +58.29% | 2M | 0.40 | $0.01 | N/A |
| MKKGY | $26.33 | +0.69% | 56.8B | 17.71 | $1.49 | +1.90% |
| MKGAF | $129.74 | +0.96% | 56.4B | 17.41 | $7.45 | +1.93% |
| HLNCF | $5.19 | +1.17% | 46.7B | 24.69 | $0.21 | +1.18% |
| TKPHF | $28.35 | +0.00% | 44.6B | 61.63 | $0.46 | +4.69% |
| IPSEY | $29.05 | +0.00% | 38.4B | 23.62 | $1.23 | +0.89% |
| SDZNY | $54.10 | +0.78% | 23.3B | -2704.75 | -$0.02 | +1.25% |
| TEVJF | $17.80 | +0.00% | 20.4B | -15.48 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| SGIOF | $18.05 | +0.00% | 15.4B | 13.08 | $1.38 | +2.31% |
Stock Comparison
EDXC vs MKKGY Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, MKKGY has a market cap of 56.8B. Regarding current trading prices, EDXC is priced at $0.01, while MKKGY trades at $26.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas MKKGY's P/E ratio is 17.71. In terms of profitability, EDXC's ROE is +0.04%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, EDXC is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs MKGAF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, MKGAF has a market cap of 56.4B. Regarding current trading prices, EDXC is priced at $0.01, while MKGAF trades at $129.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas MKGAF's P/E ratio is 17.41. In terms of profitability, EDXC's ROE is +0.04%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, EDXC is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs HLNCF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, HLNCF has a market cap of 46.7B. Regarding current trading prices, EDXC is priced at $0.01, while HLNCF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas HLNCF's P/E ratio is 24.69. In terms of profitability, EDXC's ROE is +0.04%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, EDXC is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs TKPHF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, TKPHF has a market cap of 44.6B. Regarding current trading prices, EDXC is priced at $0.01, while TKPHF trades at $28.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas TKPHF's P/E ratio is 61.63. In terms of profitability, EDXC's ROE is +0.04%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, EDXC is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs IPSEY Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, IPSEY has a market cap of 38.4B. Regarding current trading prices, EDXC is priced at $0.01, while IPSEY trades at $29.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas IPSEY's P/E ratio is 23.62. In terms of profitability, EDXC's ROE is +0.04%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, EDXC is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs SDZNY Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, SDZNY has a market cap of 23.3B. Regarding current trading prices, EDXC is priced at $0.01, while SDZNY trades at $54.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas SDZNY's P/E ratio is -2704.75. In terms of profitability, EDXC's ROE is +0.04%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, EDXC is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs TEVJF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, TEVJF has a market cap of 20.4B. Regarding current trading prices, EDXC is priced at $0.01, while TEVJF trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas TEVJF's P/E ratio is -15.48. In terms of profitability, EDXC's ROE is +0.04%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, EDXC is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs ESALY Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, EDXC is priced at $0.01, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas ESALY's P/E ratio is 20.54. In terms of profitability, EDXC's ROE is +0.04%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, EDXC is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs SGIOF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, SGIOF has a market cap of 15.4B. Regarding current trading prices, EDXC is priced at $0.01, while SGIOF trades at $18.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas SGIOF's P/E ratio is 13.08. In terms of profitability, EDXC's ROE is +0.04%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, EDXC is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs SGIOY Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, SGIOY has a market cap of 14.9B. Regarding current trading prices, EDXC is priced at $0.01, while SGIOY trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas SGIOY's P/E ratio is 12.68. In terms of profitability, EDXC's ROE is +0.04%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, EDXC is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs BIOVF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, BIOVF has a market cap of 10B. Regarding current trading prices, EDXC is priced at $0.01, while BIOVF trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas BIOVF's P/E ratio is 24.38. In terms of profitability, EDXC's ROE is +0.04%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, EDXC is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs IPSEF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, EDXC is priced at $0.01, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas IPSEF's P/E ratio is 22.81. In terms of profitability, EDXC's ROE is +0.04%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, EDXC is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs ESALF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, ESALF has a market cap of 8.3B. Regarding current trading prices, EDXC is priced at $0.01, while ESALF trades at $29.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas ESALF's P/E ratio is 26.17. In terms of profitability, EDXC's ROE is +0.04%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, EDXC is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs SFOSF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, SFOSF has a market cap of 8.2B. Regarding current trading prices, EDXC is priced at $0.01, while SFOSF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas SFOSF's P/E ratio is 13.03. In terms of profitability, EDXC's ROE is +0.04%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, EDXC is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs ESAIY Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, ESAIY has a market cap of 7.9B. Regarding current trading prices, EDXC is priced at $0.01, while ESAIY trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas ESAIY's P/E ratio is 25.08. In terms of profitability, EDXC's ROE is +0.04%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, EDXC is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs HKMPY Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, HKMPY has a market cap of 6.1B. Regarding current trading prices, EDXC is priced at $0.01, while HKMPY trades at $55.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas HKMPY's P/E ratio is 17.23. In terms of profitability, EDXC's ROE is +0.04%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, EDXC is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs HKMPF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, HKMPF has a market cap of 6.1B. Regarding current trading prices, EDXC is priced at $0.01, while HKMPF trades at $27.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas HKMPF's P/E ratio is 17.22. In terms of profitability, EDXC's ROE is +0.04%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, EDXC is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs GZPHF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, GZPHF has a market cap of 5.7B. Regarding current trading prices, EDXC is priced at $0.01, while GZPHF trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas GZPHF's P/E ratio is 9.70. In terms of profitability, EDXC's ROE is +0.04%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, EDXC is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs SGFEF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, EDXC is priced at $0.01, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas SGFEF's P/E ratio is 25.35. In terms of profitability, EDXC's ROE is +0.04%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, EDXC is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for EDXC.
EDXC vs WIBFF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, EDXC is priced at $0.01, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, EDXC's ROE is +0.04%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, EDXC is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for EDXC.
EDXC vs HLBBF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, HLBBF has a market cap of 4.2B. Regarding current trading prices, EDXC is priced at $0.01, while HLBBF trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas HLBBF's P/E ratio is 10.49. In terms of profitability, EDXC's ROE is +0.04%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, EDXC is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs LVZPF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, LVZPF has a market cap of 3.7B. Regarding current trading prices, EDXC is priced at $0.01, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, EDXC's ROE is +0.04%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, EDXC is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs HLUBF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, HLUBF has a market cap of 3.6B. Regarding current trading prices, EDXC is priced at $0.01, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas HLUBF's P/E ratio is 7.25. In terms of profitability, EDXC's ROE is +0.04%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, EDXC is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs ULIHF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, ULIHF has a market cap of 3.4B. Regarding current trading prices, EDXC is priced at $0.01, while ULIHF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas ULIHF's P/E ratio is 9.25. In terms of profitability, EDXC's ROE is +0.04%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, EDXC is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs APNHF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, EDXC is priced at $0.01, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas APNHF's P/E ratio is 12.95. In terms of profitability, EDXC's ROE is +0.04%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, EDXC is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs INVVY Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, EDXC is priced at $0.01, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas INVVY's P/E ratio is -62.42. In terms of profitability, EDXC's ROE is +0.04%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, EDXC is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs HYPMY Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, HYPMY has a market cap of 3B. Regarding current trading prices, EDXC is priced at $0.01, while HYPMY trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas HYPMY's P/E ratio is 20.65. In terms of profitability, EDXC's ROE is +0.04%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, EDXC is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs APNHY Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, APNHY has a market cap of 3B. Regarding current trading prices, EDXC is priced at $0.01, while APNHY trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas APNHY's P/E ratio is 11.94. In terms of profitability, EDXC's ROE is +0.04%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, EDXC is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs IZQVF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, EDXC is priced at $0.01, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, EDXC's ROE is +0.04%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, EDXC is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs LBTSF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, EDXC is priced at $0.01, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas LBTSF's P/E ratio is 222.67. In terms of profitability, EDXC's ROE is +0.04%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, EDXC is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs HMDCF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, EDXC is priced at $0.01, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, EDXC's ROE is +0.04%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, EDXC is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs DNPUF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, DNPUF has a market cap of 2.6B. Regarding current trading prices, EDXC is priced at $0.01, while DNPUF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas DNPUF's P/E ratio is 15.98. In terms of profitability, EDXC's ROE is +0.04%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, EDXC is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs SMDPY Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, SMDPY has a market cap of 2.4B. Regarding current trading prices, EDXC is priced at $0.01, while SMDPY trades at $6.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas SMDPY's P/E ratio is 14.83. In terms of profitability, EDXC's ROE is +0.04%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, EDXC is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for EDXC.
EDXC vs THCBF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, EDXC is priced at $0.01, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas THCBF's P/E ratio is -0.10. In terms of profitability, EDXC's ROE is +0.04%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, EDXC is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for EDXC.
EDXC vs CHSYF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, EDXC is priced at $0.01, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, EDXC's ROE is +0.04%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, EDXC is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs DMPHF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, EDXC is priced at $0.01, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, EDXC's ROE is +0.04%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, EDXC is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs HTSUF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, EDXC is priced at $0.01, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas HTSUF's P/E ratio is 14.19. In terms of profitability, EDXC's ROE is +0.04%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, EDXC is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs LJUIF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, EDXC is priced at $0.01, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, EDXC's ROE is +0.04%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, EDXC is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs ARSUF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, EDXC is priced at $0.01, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, EDXC's ROE is +0.04%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, EDXC is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs TSMRF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, EDXC is priced at $0.01, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas TSMRF's P/E ratio is 10.99. In terms of profitability, EDXC's ROE is +0.04%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, EDXC is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs NPNKF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, EDXC is priced at $0.01, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas NPNKF's P/E ratio is 7.66. In terms of profitability, EDXC's ROE is +0.04%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, EDXC is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs YIHCF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, YIHCF has a market cap of 1.6B. Regarding current trading prices, EDXC is priced at $0.01, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, EDXC's ROE is +0.04%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, EDXC is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs MITPF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, EDXC is priced at $0.01, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas MITPF's P/E ratio is -10.81. In terms of profitability, EDXC's ROE is +0.04%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, EDXC is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for EDXC.
EDXC vs CHIZF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, CHIZF has a market cap of 1.6B. Regarding current trading prices, EDXC is priced at $0.01, while CHIZF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas CHIZF's P/E ratio is 15.63. In terms of profitability, EDXC's ROE is +0.04%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, EDXC is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs KARBF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, EDXC is priced at $0.01, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas KARBF's P/E ratio is 262.50. In terms of profitability, EDXC's ROE is +0.04%, compared to KARBF's ROE of N/A. Regarding short-term risk, EDXC is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs SHEZF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, SHEZF has a market cap of 1.5B. Regarding current trading prices, EDXC is priced at $0.01, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, EDXC's ROE is +0.04%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, EDXC is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs EVOTF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, EDXC is priced at $0.01, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, EDXC's ROE is +0.04%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, EDXC is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs NPPNY Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, EDXC is priced at $0.01, while NPPNY trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas NPPNY's P/E ratio is 6.18. In terms of profitability, EDXC's ROE is +0.04%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, EDXC is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs GTBIF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, GTBIF has a market cap of 1.2B. Regarding current trading prices, EDXC is priced at $0.01, while GTBIF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas GTBIF's P/E ratio is 24.67. In terms of profitability, EDXC's ROE is +0.04%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, EDXC is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs KSPHF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, KSPHF has a market cap of 1.2B. Regarding current trading prices, EDXC is priced at $0.01, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas KSPHF's P/E ratio is 14.51. In terms of profitability, EDXC's ROE is +0.04%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, EDXC is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs GNMLF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, EDXC is priced at $0.01, while GNMLF trades at $1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas GNMLF's P/E ratio is 9.67. In terms of profitability, EDXC's ROE is +0.04%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, EDXC is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs SWGHF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, EDXC is priced at $0.01, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas SWGHF's P/E ratio is 15.78. In terms of profitability, EDXC's ROE is +0.04%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, EDXC is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs KKPCF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, EDXC is priced at $0.01, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas KKPCF's P/E ratio is 11.15. In terms of profitability, EDXC's ROE is +0.04%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, EDXC is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs CASBF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, CASBF has a market cap of 985.3M. Regarding current trading prices, EDXC is priced at $0.01, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas CASBF's P/E ratio is -15.24. In terms of profitability, EDXC's ROE is +0.04%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, EDXC is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs SHPHF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, EDXC is priced at $0.01, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, EDXC's ROE is +0.04%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, EDXC is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs LVTTF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, LVTTF has a market cap of 894.1M. Regarding current trading prices, EDXC is priced at $0.01, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, EDXC's ROE is +0.04%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, EDXC is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for EDXC.
EDXC vs EVRRF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, EVRRF has a market cap of 893.1M. Regarding current trading prices, EDXC is priced at $0.01, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, EDXC's ROE is +0.04%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, EDXC is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs BIOGY Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, BIOGY has a market cap of 884.8M. Regarding current trading prices, EDXC is priced at $0.01, while BIOGY trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas BIOGY's P/E ratio is 28.07. In terms of profitability, EDXC's ROE is +0.04%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, EDXC is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs NRXCF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, NRXCF has a market cap of 846.4M. Regarding current trading prices, EDXC is priced at $0.01, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, EDXC's ROE is +0.04%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, EDXC is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs TWAPF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, EDXC is priced at $0.01, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas TWAPF's P/E ratio is 6.37. In terms of profitability, EDXC's ROE is +0.04%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, EDXC is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs ELTP Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, ELTP has a market cap of 774M. Regarding current trading prices, EDXC is priced at $0.01, while ELTP trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas ELTP's P/E ratio is -36.22. In terms of profitability, EDXC's ROE is +0.04%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, EDXC is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs CSWYF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, EDXC is priced at $0.01, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, EDXC's ROE is +0.04%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, EDXC is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs NIKA Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, NIKA has a market cap of 708.2M. Regarding current trading prices, EDXC is priced at $0.01, while NIKA trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas NIKA's P/E ratio is N/A. In terms of profitability, EDXC's ROE is +0.04%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, EDXC is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs TRXPF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, EDXC is priced at $0.01, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, EDXC's ROE is +0.04%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, EDXC is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs TCNNF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, TCNNF has a market cap of 677.1M. Regarding current trading prices, EDXC is priced at $0.01, while TCNNF trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas TCNNF's P/E ratio is -4.49. In terms of profitability, EDXC's ROE is +0.04%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, EDXC is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs SWDCF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, SWDCF has a market cap of 655.3M. Regarding current trading prices, EDXC is priced at $0.01, while SWDCF trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas SWDCF's P/E ratio is 68.33. In terms of profitability, EDXC's ROE is +0.04%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, EDXC is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs TRSSF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, EDXC is priced at $0.01, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, EDXC's ROE is +0.04%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, EDXC is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs CURLF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, CURLF has a market cap of 598.3M. Regarding current trading prices, EDXC is priced at $0.01, while CURLF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas CURLF's P/E ratio is -2.39. In terms of profitability, EDXC's ROE is +0.04%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, EDXC is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs PKBFF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, PKBFF has a market cap of 549.2M. Regarding current trading prices, EDXC is priced at $0.01, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas PKBFF's P/E ratio is N/A. In terms of profitability, EDXC's ROE is +0.04%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, EDXC is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs CCHWF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, EDXC is priced at $0.01, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, EDXC's ROE is +0.04%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, EDXC is more volatile compared to CCHWF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs BOIRF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, EDXC is priced at $0.01, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, EDXC's ROE is +0.04%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, EDXC is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs PEXXF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, EDXC is priced at $0.01, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, EDXC's ROE is +0.04%, compared to PEXXF's ROE of N/A. Regarding short-term risk, EDXC is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs KHTRF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, KHTRF has a market cap of 420.4M. Regarding current trading prices, EDXC is priced at $0.01, while KHTRF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas KHTRF's P/E ratio is 60.29. In terms of profitability, EDXC's ROE is +0.04%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, EDXC is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs AGYTF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, EDXC is priced at $0.01, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, EDXC's ROE is +0.04%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, EDXC is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for EDXC.
EDXC vs HUMDF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, EDXC is priced at $0.01, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, EDXC's ROE is +0.04%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, EDXC is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs GLASF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, GLASF has a market cap of 402.4M. Regarding current trading prices, EDXC is priced at $0.01, while GLASF trades at $5.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas GLASF's P/E ratio is -63.33. In terms of profitability, EDXC's ROE is +0.04%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, EDXC is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs AIHLF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, AIHLF has a market cap of 396.2M. Regarding current trading prices, EDXC is priced at $0.01, while AIHLF trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas AIHLF's P/E ratio is 8.45. In terms of profitability, EDXC's ROE is +0.04%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, EDXC is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs BHCCF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, BHCCF has a market cap of 271.2M. Regarding current trading prices, EDXC is priced at $0.01, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, EDXC's ROE is +0.04%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, EDXC is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs CPHRF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, CPHRF has a market cap of 236.8M. Regarding current trading prices, EDXC is priced at $0.01, while CPHRF trades at $9.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas CPHRF's P/E ratio is 25.67. In terms of profitability, EDXC's ROE is +0.04%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, EDXC is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs PLNHF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, EDXC is priced at $0.01, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, EDXC's ROE is +0.04%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, EDXC is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs VRNOF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, VRNOF has a market cap of 176.3M. Regarding current trading prices, EDXC is priced at $0.01, while VRNOF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas VRNOF's P/E ratio is -0.49. In terms of profitability, EDXC's ROE is +0.04%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, EDXC is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs CRLBF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, CRLBF has a market cap of 168.7M. Regarding current trading prices, EDXC is priced at $0.01, while CRLBF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas CRLBF's P/E ratio is -2.08. In terms of profitability, EDXC's ROE is +0.04%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, EDXC is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs CBSTF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, CBSTF has a market cap of 152.3M. Regarding current trading prices, EDXC is priced at $0.01, while CBSTF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas CBSTF's P/E ratio is -0.22. In terms of profitability, EDXC's ROE is +0.04%, compared to CBSTF's ROE of +10.11%. Regarding short-term risk, EDXC is more volatile compared to CBSTF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs PHCUF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, PHCUF has a market cap of 137.2M. Regarding current trading prices, EDXC is priced at $0.01, while PHCUF trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas PHCUF's P/E ratio is 515.00. In terms of profitability, EDXC's ROE is +0.04%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, EDXC is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs COPHF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, EDXC is priced at $0.01, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas COPHF's P/E ratio is -0.02. In terms of profitability, EDXC's ROE is +0.04%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, EDXC is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for EDXC.
EDXC vs STMH Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, STMH has a market cap of 126.2M. Regarding current trading prices, EDXC is priced at $0.01, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas STMH's P/E ratio is N/A. In terms of profitability, EDXC's ROE is +0.04%, compared to STMH's ROE of -2.75%. Regarding short-term risk, EDXC is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for EDXC.
EDXC vs NWPN Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, EDXC is priced at $0.01, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas NWPN's P/E ratio is -0.04. In terms of profitability, EDXC's ROE is +0.04%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, EDXC is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for EDXC.
EDXC vs CHALF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, CHALF has a market cap of 116.3M. Regarding current trading prices, EDXC is priced at $0.01, while CHALF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas CHALF's P/E ratio is N/A. In terms of profitability, EDXC's ROE is +0.04%, compared to CHALF's ROE of +0.00%. Regarding short-term risk, EDXC is less volatile compared to CHALF. This indicates potentially lower risk in terms of short-term price fluctuations for EDXC.
EDXC vs HLTRF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, HLTRF has a market cap of 115.5M. Regarding current trading prices, EDXC is priced at $0.01, while HLTRF trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas HLTRF's P/E ratio is -6.42. In terms of profitability, EDXC's ROE is +0.04%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, EDXC is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs LPCUF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, EDXC is priced at $0.01, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, EDXC's ROE is +0.04%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, EDXC is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs CNVCF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, EDXC is priced at $0.01, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, EDXC's ROE is +0.04%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, EDXC is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs BIOYF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, BIOYF has a market cap of 98.4M. Regarding current trading prices, EDXC is priced at $0.01, while BIOYF trades at $8.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas BIOYF's P/E ratio is 17.50. In terms of profitability, EDXC's ROE is +0.04%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, EDXC is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs GRUSF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, GRUSF has a market cap of 92.9M. Regarding current trading prices, EDXC is priced at $0.01, while GRUSF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas GRUSF's P/E ratio is -7.50. In terms of profitability, EDXC's ROE is +0.04%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, EDXC is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs LOVFF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, LOVFF has a market cap of 91.1M. Regarding current trading prices, EDXC is priced at $0.01, while LOVFF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas LOVFF's P/E ratio is 9.96. In terms of profitability, EDXC's ROE is +0.04%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, EDXC is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs DUTV Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, DUTV has a market cap of 90.1M. Regarding current trading prices, EDXC is priced at $0.01, while DUTV trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas DUTV's P/E ratio is N/A. In terms of profitability, EDXC's ROE is +0.04%, compared to DUTV's ROE of +0.02%. Regarding short-term risk, EDXC is more volatile compared to DUTV. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs CBWTF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, CBWTF has a market cap of 88.7M. Regarding current trading prices, EDXC is priced at $0.01, while CBWTF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas CBWTF's P/E ratio is 3.37. In terms of profitability, EDXC's ROE is +0.04%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, EDXC is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs LRDSF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, LRDSF has a market cap of 84.2M. Regarding current trading prices, EDXC is priced at $0.01, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, EDXC's ROE is +0.04%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, EDXC is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for EDXC.
EDXC vs GBLP Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, GBLP has a market cap of 83M. Regarding current trading prices, EDXC is priced at $0.01, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas GBLP's P/E ratio is -0.67. In terms of profitability, EDXC's ROE is +0.04%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, EDXC is more volatile compared to GBLP. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.
EDXC vs MEDXF Comparison
EDXC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDXC stands at 2M. In comparison, MEDXF has a market cap of 75.5M. Regarding current trading prices, EDXC is priced at $0.01, while MEDXF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDXC currently has a P/E ratio of 0.40, whereas MEDXF's P/E ratio is 29.25. In terms of profitability, EDXC's ROE is +0.04%, compared to MEDXF's ROE of +0.11%. Regarding short-term risk, EDXC is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for EDXC.